Andrew Avery
7Patents
1h-index
26Co-inventors
43Inventor score
Filing activity: Jul 11, 2019 → Oct 17, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11447566B2 | Anti-tissue factor antibodies, antibody-drug conjugates, and related methods | Physics | 1 | Active |
| US12269882B1 | Antigen binding polypeptides | Chemistry; Metallurgy | 1 | Active |
| US12215167B2 | Anti-tissue factor antibodies, antibody-drug conjugates, and related methods | Physics | 0 | Active |
| US12252531B2 | Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12122823B2 | Isoform-selective TGFB1 inhibitors and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12403194B2 | Compositions for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US11130803B2 | Isoform-selective TGFβ1 inhibitors and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.